{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:43Z","timestamp":1793982283331,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hematopoietic cell transplantation, cellular and gene therapies, and (CAR)-T cells have revolutionized outcomes in hematologic disorders. However, major disparities persist in their availability, accessibility, and affordability, particularly in low- and middle-income countries (LMICs). The EBMT Global Committee aims to address these inequalities. A structured survey was distributed to EBMT members to identify regional and thematic priorities, assess current infrastructure, and assess willingness to contribute to global initiatives. Responses were analyzed descriptively and served as the basis for the current statement paper. A total of 145 responses from 43 countries were collected. Most respondents (67.1%) reported working in JACIE- or FACT-accredited centers. The highest priority regions for EBMT outreach were Eastern Europe (non-EU) (43.9%), Latin America (38.2%), and Africa (33.5%), followed by the Middle East (29.5%). The leading thematic priorities were education and training (74.3%), scientific collaboration (56.0%), and registry development (43.4%). Most respondents expressed willingness to actively contribute, particularly in educational activities (59.7%). Qualitative responses emphasized the need for practical guidelines, mentorship programs, telemedicine, virtual discussion\/clinical rounds on difficult cases, and support for LMIC capacity building. The EBMT community strongly supports an expanded global role focused on education, capacity building, and collaboration in underserved regions.<\/jats:p>","DOI":"10.1038\/s41409-026-03008-7","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:24:47Z","timestamp":1786454687000},"page":"1475-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global Committee"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-1265","authenticated-orcid":false,"given":"Arnon","family":"Nagler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-5769","authenticated-orcid":false,"given":"Norbert Claude","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4889","authenticated-orcid":false,"given":"Christian","family":"Chabannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Puigvent\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e9e","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5519-9154","authenticated-orcid":false,"given":"Isabel","family":"S\u00e1nchez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Rintala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-2544","authenticated-orcid":false,"given":"Yann","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6512-6080","authenticated-orcid":false,"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-9725","authenticated-orcid":false,"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-6178","authenticated-orcid":false,"given":"Michelle","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-1845","authenticated-orcid":false,"given":"Hilda","family":"Mekelenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-091X","authenticated-orcid":false,"given":"Donal P.","family":"McLornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5109","authenticated-orcid":false,"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6970","authenticated-orcid":false,"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-2765","authenticated-orcid":false,"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0123","authenticated-orcid":false,"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-5328","authenticated-orcid":false,"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"3008_CR1","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/jcm14103379","volume":"14","author":"G Milone","year":"2025","unstructured":"Milone G, Leotta S, Cupri A. Hematopoietic stem cell transplantation: recent advances. J Clin Med. 2025;14:3379.","journal-title":"J Clin Med"},{"key":"3008_CR2","doi-asserted-by":"crossref","unstructured":"Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024.","DOI":"10.1007\/978-3-031-44080-9"},{"key":"3008_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1608768","volume":"16","author":"Z Yu","year":"2025","unstructured":"Yu Z, Jing C, Xie L, Min L, Li L, Wang Z, et al. Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis. Front Immunol. 2025;16:1608768.","journal-title":"Front Immunol"},{"key":"3008_CR4","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.ymthe.2025.04.029","volume":"33","author":"T John","year":"2025","unstructured":"John T, Czechowicz A. Review: Clinical hematopoietic stem cell-based gene therapy. Molecular Therapy. 2025;33:2663\u201378.","journal-title":"Molecular Therapy"},{"key":"3008_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano Ispizua A. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002;117:451\u201368.","journal-title":"Br J Haematol"},{"key":"3008_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3324\/haematol.2012.076349","volume":"98","author":"A Gratwohl","year":"2013","unstructured":"Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, et al. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica. 2013;98:1282\u201390.","journal-title":"Haematologica"},{"key":"3008_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2015.11.001","volume":"22","author":"J Apperley","year":"2016","unstructured":"Apperley J, Niederwieser D, Huang XJ. Haploidentical hematopoietic stem cell transplantation: a global overview comparing Asia, the European Union, and the United States. Biol Blood Marrow Transplant. 2016;22:23\u201326.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3008_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41409-024-02459-0","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, et al. Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT. Bone Marrow Transplant. 2025b;60:227\u201336.","journal-title":"Bone Marrow Transplant"},{"key":"3008_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/hemoncstem.HEMONCSTEM-D-24-00011","volume":"17","author":"HT Greinix","year":"2024","unstructured":"Greinix HT, Iftikhar R, Chaudhry QUN, Ahmed P, Al-Khabori M, Gaziev J, et al. Special Report: Summary of the eighth workshop of the worldwide network for blood and marrow transplantation on the status and issues related to hematopoietic stem cell transplantation in near-east countries, held in Pakistan from September 22 to 23, 2022. Hematol Oncol Stem Cell Ther. 2024;17:190\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"3008_CR10","doi-asserted-by":"publisher","first-page":"279.e1","DOI":"10.1016\/j.jtct.2022.12.013","volume":"29","author":"MC Tokaz","year":"2023","unstructured":"Tokaz MC, Baldomero H, Cowan AJ. An analysis of the worldwide utilization of hematopoietic stem cell transplantation for acute myeloid leukemia. Transplant Cell Ther. 2023;29:279.e1\u2013279. e10.","journal-title":"Transplant Cell Ther"},{"key":"3008_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bglo.2025.100051","volume":"2","author":"DV Cl\u00e9","year":"2026","unstructured":"Cl\u00e9 DV, Donadel CD, Calado RT. CAR-T in resource-limited regions. Blood Global Hematology. 2026;2:100051.","journal-title":"Blood Global Hematology"},{"key":"3008_CR12","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1182\/blood.2025030872","volume":"147","author":"AY Ge","year":"2026","unstructured":"Ge AY, Feldman WB, Kaiser MF, Rejeski K, Iacoboni G, Narula G, et al. Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries. Blood. 2026;147:1521\u201331.","journal-title":"Blood"},{"key":"3008_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41409-026-02919-9","volume":"61","author":"R Greco","year":"2026","unstructured":"Greco R, S\u00e1nchez-Ortega I, Risitano A, Kalwak K, Ruggeri A, Kleovoulou I, et al. The 2024 EBMT Activity Report: Crossing One Million HCTs and 20,000 CAR-T. A Landmark in Cellular Therapy. Bone Marrow Transplant. 2026;61:899\u2013912.","journal-title":"Bone Marrow Transplant"},{"key":"3008_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.hemonc.2019.08.002","volume":"13","author":"M Aljurf","year":"2020","unstructured":"Aljurf M, Weisdorf D, Hashmi SK. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (part II): clinical, technical, and socio-economic considerations. Hematol Oncol Stem Cell Ther. 2020;13:7\u201316.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"3008_CR15","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41409-019-0476-6","volume":"54","author":"M Aljurf","year":"2019","unstructured":"Aljurf M, Weisdorf D, Alfraih F, Szer J, M\u00fcller C, Confer D, et al. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries. Marrow Transplant. 2019;54:1179\u201388.","journal-title":"Marrow Transplant"},{"key":"3008_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.hemonc.2019.08.001","volume":"13","author":"MC Pasquini","year":"2020","unstructured":"Pasquini MC, Srivastava A, Ahmed SO. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (part I): minimum requirements and beyond. Hematol Oncol Stem Cell Ther. 2020;13:131\u201342.","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"3008_CR17","unstructured":"Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, et al. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica. 2024;10913282-3294."},{"key":"3008_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","volume":"107","author":"D Niederwieser","year":"2022","unstructured":"Niederwieser D, Baldomero H, Bazuaye N. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica. 2022;107:1045\u201353.","journal-title":"Haematologica"},{"key":"3008_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jcyt.2020.12.016","volume":"23","author":"MA Bekadja","year":"2021","unstructured":"Bekadja MA, Boumendil A, Blaise D, Chevallier P, Peggs KS, Salles G, et al. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry. Cytotherapy. 2021;23:483\u20137.","journal-title":"Cytotherapy"},{"key":"3008_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41409-024-02431-y","volume":"60","author":"MA Bekadja","year":"2025","unstructured":"Bekadja MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, Garderet L, Yakoub-Agha I, et al. non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation. Bone Marrow Transplant. 2025;60:19\u201327.","journal-title":"Bone Marrow Transplant"},{"key":"3008_CR21","unstructured":"Orofino G, Greco R, Badoglio M, Ambron P, Becilli M, Bramanti S, et al. CAR-T Cell Activity for Autoimmune Diseases across EBMT centers in 2026: a Survey on behalf of EBMT ADWP and CTIWP (submitted)."},{"key":"3008_CR22","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1470-2045(15)00161-8","volume":"16","author":"S Stulac","year":"2015","unstructured":"Stulac S, Binagwaho A, Tapela NM, Wagner CM, Muhimpundu MA, Ngabo F, et al. Capacity building for oncology programs in sub-Saharan Africa: the Rwanda experience. Lancet Oncol. 2015;16:e405\u201313.","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1038\/s41409-026-03046-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03008-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03008-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:44Z","timestamp":1793978864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03008-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-03008-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the 4<sup>th<\/sup> paragraph at the beginning of the methods section the words \u2018are approved by the releva\u2019 have been removed.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41409-026-03046-1","URL":"https:\/\/doi.org\/10.1038\/s41409-026-03046-1","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The scientific boards of the Acute Leukemia Working Party of the EBMT approved this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}